Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
309M
-
Number of holders
-
145
-
Total 13F shares, excl. options
-
174M
-
Shares change
-
+12.5M
-
Total reported value, excl. options
-
$1.75B
-
Value change
-
+$127M
-
Put/Call ratio
-
0.36
-
Number of buys
-
68
-
Number of sells
-
-62
-
Price
-
$10.07
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2017
183 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q2 2017.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 174M shares
of 309M outstanding shares and own 56.42% of the company stock.
Largest 10 shareholders include FMR LLC (21.4M shares), PERCEPTIVE ADVISORS LLC (17.3M shares), Redmile Group, LLC (12M shares), BlackRock Inc. (11.8M shares), VANGUARD GROUP INC (9.12M shares), JENNISON ASSOCIATES LLC (8.93M shares), Palo Alto Investors, LLC (7.94M shares), MORGAN STANLEY (7.25M shares), JANUS HENDERSON GROUP PLC (7.03M shares), and WELLINGTON MANAGEMENT GROUP LLP (5.99M shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.